Neogenix Oncology, Inc. - Product Pipeline Analysis

Summary

Neogenix Oncology, Inc. (NOI) is a clinical stage biotechnology company, based in the US. The company develops therapeutic and diagnostic products for the early detection and treatment of cancer. Its antibody drug candidates and diagnostics are designed to detect and target the tumor without destroying healthy cells. The company is uniquely positioned to create innovative therapeutics through the use of proprietary cancer vaccines, several of which have demonstrated success in human trials. Its products include NPC-1C antibody for the treatment of pancreatic and colorectal cancer, h16C3 and 31.1 antibodies for pancreatic and colorectal cancer and serum ELISA test for pancreatic colorectal cancer. The company was founded in 2003. NOI is headquartered in Great Neck, New York, the US.

This report is a source for data, analysis and actionable intelligence on the Neogenix Oncology, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize. SHOW LESS READ MORE >

List of Tables
List of Figures
Key Facts
Neogenix Oncology, Inc. - Major Products and Services
Neogenix Oncology, Inc. Pipeline Products by Equipment Type
Neogenix Oncology, Inc. Pipeline Products by Development Stage
Neogenix Oncology, Inc. Pipeline Products by Therapy Area
Neogenix Oncology, Inc. Pipeline Products by Trial Phase
Neogenix Oncology, Inc. Pipeline Products by Milestone Summary
Diagnostic Assay - Breast Cancer
Diagnostic Assay - Breast Cancer Product Status
Diagnostic Assay - Breast Cancer Product Description
Diagnostic Assay - Breast Cancer Product Patent Details
Diagnostic Assay - Lung Cancer
Diagnostic Assay - Lung Cancer Product Status
Diagnostic Assay - Lung Cancer Product Description
Diagnostic Assay - Lung Cancer Product Patent Details
Diagnostic Assay - Ovarian Cancer
Diagnostic Assay - Ovarian Cancer Product Status
Diagnostic Assay - Ovarian Cancer Product Description
Diagnostic Assay - Ovarian Cancer Product Patent Details
Diagnostic Assay - Prostate Cancer
Diagnostic Assay - Prostate Cancer Product Status
Diagnostic Assay - Prostate Cancer Product Description
Diagnostic Assay - Prostate Cancer Product Patent Details
Diagnostic Assay - Cervical Cancer
Diagnostic Assay - Cervical Cancer Product Status
Diagnostic Assay - Cervical Cancer Product Description
Diagnostic Assay - Cervical Cancer Product Patent Details
Diagnostic Assay - Colorectal Cancer
Diagnostic Assay - Colorectal Cancer Product Status
Diagnostic Assay - Colorectal Cancer Product Description
Diagnostic Assay - Colorectal Cancer Product Milestone
Diagnostic Assay - Colorectal Cancer Clinical Trial
Diagnostic Assay - Colorectal Cancer Product Patent Details
Diagnostic Assay - Pancreatic Cancer
Diagnostic Assay - Pancreatic Cancer Product Status
Diagnostic Assay - Pancreatic Cancer Product Description
Diagnostic Assay - Pancreatic Cancer Product Milestone
Diagnostic Assay - Pancreatic Cancer Product Patent Details
Neogenix Oncology, Inc. - Key Competitors
Neogenix Oncology, Inc. - Key Employees
Neogenix Oncology, Inc. - Locations And Subsidiaries
Head Office
Recent Developments
Neogenix Oncology, Inc., Recent Developments
Jun 13, 2011: Neogenix Oncology Enhances Management Consulting Team
Feb 16, 2011: Neogenix Oncology Appoints Albine Martin As COO
Jan 05, 2011: Neogenix Oncology Receives Additional Federal Grant, Bringing Total Award To Over $730,000
Appendix
Methodology
About Us
Contact Us
Disclaimer

List of Tables
Neogenix Oncology, Inc., Key Facts
Neogenix Oncology, Inc. Key Pipeline Products by Equipment Type
Neogenix Oncology, Inc. Key Pipeline Products by Therapy Area
Neogenix Oncology, Inc. Key Pipeline Products by Development Stage
Neogenix Oncology, Inc. Key Pipeline Products by Trial Phase
Neogenix Oncology, Inc., Key Facts
Neogenix Oncology, Inc., Major Products and Services
Neogenix Oncology, Inc. Number of Pipeline Products by Equipment Type
Neogenix Oncology, Inc. Pipeline Products by Equipment Type
Neogenix Oncology, Inc. Number of Pipeline Products by Development Stage
Neogenix Oncology, Inc. Pipeline Products by Development Stage
Neogenix Oncology, Inc. Number of Pipeline Products by Therapy Area
Neogenix Oncology, Inc. Pipeline Products by Therapy Area
Neogenix Oncology, Inc. Number of Pipeline Products by Trial Phase
Neogenix Oncology, Inc. Pipeline Products by Trial Phase
Neogenix Oncology, Inc. Number of Pipeline Products By Milestone Summary
Neogenix Oncology, Inc. Pipeline Products by Milestone Summary
Diagnostic Assay - Breast Cancer - Product Status
Diagnostic Assay - Breast Cancer - Product Description
Diagnostic Assay - Breast Cancer - Patent Details1
Diagnostic Assay - Breast Cancer - Patent Details2
Diagnostic Assay - Breast Cancer - Patent Details3
Diagnostic Assay - Breast Cancer - Patent Details4
Diagnostic Assay - Lung Cancer - Product Status
Diagnostic Assay - Lung Cancer - Product Description
Diagnostic Assay - Lung Cancer - Patent Details1
Diagnostic Assay - Lung Cancer - Patent Details2
Diagnostic Assay - Lung Cancer - Patent Details3
Diagnostic Assay - Lung Cancer - Patent Details4
Diagnostic Assay - Ovarian Cancer - Product Status
Diagnostic Assay - Ovarian Cancer - Product Description
Diagnostic Assay - Ovarian Cancer - Patent Details1
Diagnostic Assay - Ovarian Cancer - Patent Details2
Diagnostic Assay - Ovarian Cancer - Patent Details3
Diagnostic Assay - Ovarian Cancer - Patent Details4
Diagnostic Assay - Prostate Cancer - Product Status
Diagnostic Assay - Prostate Cancer - Product Description
Diagnostic Assay - Prostate Cancer - Patent Details1
Diagnostic Assay - Prostate Cancer - Patent Details2
Diagnostic Assay - Prostate Cancer - Patent Details3
Diagnostic Assay - Cervical Cancer - Product Status
Diagnostic Assay - Cervical Cancer - Product Description
Diagnostic Assay - Cervical Cancer - Patent Details1
Diagnostic Assay - Cervical Cancer - Patent Details2
Diagnostic Assay - Cervical Cancer - Patent Details3
Diagnostic Assay - Colorectal Cancer - Product Status
Diagnostic Assay - Colorectal Cancer - Product Description
Diagnostic Assay - Colorectal Cancer - Product Milestone
Diagnostic Assay - Colorectal Cancer - Neogenix Oncology To Begin First Clinical Trial For A New Generation Of Diagnostic Products
Diagnostic Assay - Colorectal Cancer - A Phase 1/2A Therapeutic, Open Label, Multi-Center Clinical Trial of NPC-1C, a Chimeric Monoclonal Antibody, in Adults With Recurrent, Locally Advanced Unresectable or Metastatic Pancreatic and Colorectal Cancer After Standard Therapy
Diagnostic Assay - Colorectal Cancer - Patent Details1
Diagnostic Assay - Colorectal Cancer - Patent Details2
Diagnostic Assay - Colorectal Cancer - Patent Details3
Diagnostic Assay - Colorectal Cancer - Patent Details4
Diagnostic Assay - Colorectal Cancer - Patent Details5
Diagnostic Assay - Colorectal Cancer - Patent Details6
Diagnostic Assay - Colorectal Cancer - Patent Details7
Diagnostic Assay - Colorectal Cancer - Patent Details8
Diagnostic Assay - Pancreatic Cancer - Product Status
Diagnostic Assay - Pancreatic Cancer - Product Description
Diagnostic Assay - Pancreatic Cancer - Product Milestone
Diagnostic Assay - Pancreatic Cancer - Patent Details1
Diagnostic Assay - Pancreatic Cancer - Patent Details2
Diagnostic Assay - Pancreatic Cancer - Patent Details3
Diagnostic Assay - Pancreatic Cancer - Patent Details4
Diagnostic Assay - Pancreatic Cancer - Patent Details5
Diagnostic Assay - Pancreatic Cancer - Patent Details6
Diagnostic Assay - Pancreatic Cancer - Patent Details7
Diagnostic Assay - Pancreatic Cancer - Patent Details8
Diagnostic Assay - Pancreatic Cancer - Patent Details9
Neogenix Oncology, Inc., Key Employees

List of Figures
Neogenix Oncology, Inc. Pipeline Products by Equipment Type
Neogenix Oncology, Inc. Pipeline Products by Development Stage
Neogenix Oncology, Inc. Pipeline Products by Therapy Area
Neogenix Oncology, Inc. Pipeline Products by Trial Phase
Neogenix Oncology, Inc. Pipeline Products by Milestone Summary

Abeille Pharmaceuticals, Inc.
Advanced BioScience Laboratories, Inc.
Accelerate Brain Cancer Cure
Avanti Therapeutics
Arlington Cancer Center